Palisade Bio, Inc. · NASDAQ:PALI
Commodore Capital LP reported a 7.20% stake in Palisade Bio, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Commodore Capital LP reported a 7.20% stake in Palisade Bio, Inc., 12,366,776 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 7.20%
- Shares
- 12,366,776
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 7.20% | 12,366,776 |
| Commodore Capital Master LP | 7.20% | 12,366,776 |
| Robert Egen Atkinson | 7.20% | 12,366,776 |
| Michael Kramarz | 7.20% | 12,366,776 |
Source
Related
- Palisade Bio, Inc.
- Commodore Capital LP
- Palisade Bio, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G · Commodore Capital LP · Oct 8, 2025
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Form 4 · Finley John David · Aug 21, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026